1,181
Views
1
CrossRef citations to date
0
Altmetric
Clinical Study

The Pharmacodynamics of Vecuronium in Chronic Renal Failure Patients: The Impact of Different Priming Doses

&
Pages 827-833 | Received 29 Sep 2011, Accepted 10 Apr 2012, Published online: 18 May 2012

REFERENCES

  • Foldes F. Rapid tracheal intubation with non-depolarization neuromuscular blocking drugs: The priming principle. Br J Anesth. 1984;56:663.
  • Hunter JM. Muscle relaxant in renal disease. Acta Anesthesiol Scand. 1994;38:2–5.
  • Toboada JA, Rupp SM, Miller RD. Refining the priming principle for vecuronium during rapid-sequence induction of anesthesia. Anesthesiology. 1986;64:243–247.
  • Mehta MP, Choi ww, Gergis SD, Sokoll MD, Adolphson AJ. Facilitation of rapid endotrachel intubation with divided doses of nondepolarizing neuromuscular blocking drugs. Anesthesiology. 1985;62:392–395.
  • Schwarz S, Ilias W, lackner F, Mayrhofer O, Foldes FF. Rapid tracheal intubation with vecuronium: The priming principle. Anesthesiology. 1985;62:388–391.
  • Kopman AF, Khan NA, Neuman GG. Precurarization and priming: A theoretical analysis of safety and timing. Anesth Analg. 2001;93:1253–1256.
  • Henning RH, Wierda JM, Scaf AH, Marescau B, De Deyn PP, Agoston S. Increased sensitivity to vecuronium in patients with chronic renal failure. Drug Invest. 1993;5:98–107.
  • Sakamoto H, Takita K, Kemmotsu O, Morimoto Y, Mayumi T. Increased sensitivity to vecuronium and prolonged duration of its action in patients with end-stage renal failure. J Clin Anesth. 2001;13:193–197.
  • Stevens JB, Walker SC, Fontenot JP. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during out patient anesthesia. Anesth Analg. 1997;85:1278–1283.
  • Kopman AF, Klewicka MM, Neuman GG. An alternate method for estimating the dose-response relationship of neuromuscular blocking drugs. Anesth Analg. 2000;90:1191–1197.
  • Sparr HJ. Choice of muscle relaxant for rapid-sequence induction. Eur J Anaesthesiol. 2001;18(Suppl. 23):71–76.
  • Iwasaki H, Yamauchi M, Narimatsu E, Yamakaga M, Tsuchida H, Namiki A. Onset of vecuronium neuromuscular blockade at the hand with an arterio-venour shunt. Can J Anesth. 1997;44:1208–1210.
  • Brull SJ, Ehrenwerth J, Siverman DG. Stimulation with submaximal current for train-of-four monitoring. Anesthesiology. 1990;72:629–632.
  • Cooper R, Mirakhur RK, Clark RSJ, Boules Z. Comparison of intubating conditions after administration of org 9426 (rocuronium) and suxamethonium. Br J Anesth. 1992;69: 269–273.
  • Sieber TJ, Zbinden AM, Guratolo M, Shorten GD. Tracheal intubation with rocuronium using the timing principle. Anesth Analg. 1998;86:1137–1140.
  • Yentis SM. Suxamethonium and hyperkalaemia. Anesth Intensive Care. 1990;18:92–101.
  • Naguib M, Abdullatif M, Absood GH. The optimal priming dose of atracurium. Can. J. Anesth. 1986;33:453–457.
  • Mak PK, Irwin MG. The effect cisatracurium and rocuronium on cisatracurium precurarization and the priming principle. J Clin Anesth. 2004;16:83–87.
  • Puhringer FK, Mitterschiffthaler G, Khuenl-Brady KS, Spar HJ, Benzer A. The onset of pipecuronium following application of the priming principle. Eur J Anaesthesiol. 1996;13:478–482.
  • Donati F, Meistelman C. A kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugs. J Pharmacokinet Biopharm. 1991;19:537–552.
  • Donati F. The priming sega: Where do stand now? Can J Anesth. 1998;35:1–4.
  • Hull CJ. Pharmacodynamics of non-depolarizing neuromuscular blocking agent. Br J Anesth. 1982;54:169–182.
  • Feldman SA. Neuromuscular Block. Oxford: Butterworth-Heinemann; 1996.
  • Jones RM. The priming principle: How does it work and should we be using it? Br J Anesth. 1989;63:1–3.
  • Wierda JM, Proost JH. Structure-pharmocodynamic-pharmocokinetic relationships of steroidal neuromuscular blocking agent. Eur J Anaesthiol. 1995;11:45–54.
  • Aziz L, Jahangir SM, Choudhury NS, Rahman K, Ohta Y, Hirakawa M. Effect of priming with vecuronium and rocronium on young and Elderly patients. Anesth Analg. 1997;85:663–666.
  • Chauvin M, Lebrault C, Duvaldestin P. The neuromuscular blocking effect of rocuronium on the human diaphragm. Anesth Analg. 1987;66:117–122.
  • D’Honneur G, Gall O, Gerard A, Rimaniol JM, Lambert Y, Duvaldestin P. Priming doses, of atracurium and vecuronium depress swallowing in human. Anesthesiology. 1992;77: 1070–1073.
  • Wigand DA, Latz B, Zwillich CW, Wiegand L. Genihyoid muscle activity in normal men during wakefulness and sleep. J Appl Physiol. 1990;69:1262–1269.
  • Saitoh Y, Kaneda K, Murakawa M. Onset of vecuronium-induced neuromuscular block after a long priming interval. J Anesthesia. 2002;16:102–107.
  • Tripathi M, Singh PK, Ambesh SP, Kaushik. S. Comparison of sensitivity of neuromuscular monitoring tests: Twitch vs tetanic test. J Anesth. 1997;11:245–249.
  • Agoston S, Salt P, Newton D, Bencini A, Boonsma P, Edrmann W. The neuromuscular blocking action of Org NC45, a new pancuronium derivative in anesthetized patients. B J Anesth. 1980;52:53S–59S.
  • Gergis SD, Sokoll MD, Mehta M, Kemmostu O, Rudd GD. Intubation conditions after atracrium and suxamethonium. Br. J Anesth. 1983;55:83S–86S.
  • Kopman AF, Klewicka MM, Kopman DJ, Neuman GG. Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short and ultrashort duration. Anesthesiology. 1999;90:425–431.
  • Huemer G, Schwarz S, Gilly H, Weindlmayr- Goettel M, Plainer B, Lackner F. Pharmacodynamics pharmacokinetics and intubation conditions after priming with three different doses of vecuronium. Anesth Analag. 1995;80:538–542.
  • Mahajan RP, Laverty J. Lung function after vecuronium pretreatment in young healthy patients. Br J Anesth. 1992;69: 318–319.
  • Mahajan RP, Hennessy N, Aitkenhead AR. Effect of priming dose of vecuronium on lung function in elderly patient. Anesth Analg. 1993;77:1198–1202.
  • Beauvoir C, Peray P, Daures JP, Peschaud JL, D’Athis F. Pharmacodynamics of vecuronium in patients with and without renal failure: A meta analysis. Can J Anesth. 1993;40:696–702.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.